# ARS Pharmaceuticals, Inc.: Form DEF 14A, filed Apr 29, 2026

- Company: [ARS Pharmaceuticals, Inc.](/companies/spry.md) (CIK 1671858)
- Form: DEF 14A
- Filed: 2026-04-29
- Accepted by EDGAR: Apr 29, 2026, 16:00 ET
- Period: 2026-06-24
- Accession: 0001193125-26-191433
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1671858/000119312526191433/spry-20260429.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671858/000119312526191433/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1671858/000119312526191433/spry-20260429.htm

Filed Apr 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-191433. Last ingested by Listed: Nov 10, 2026, 04:18 ET. No prices; not investment advice.
